Results of the QIS5 Report Short Version

Similar documents
Results of the QIS5 Report

The Solvency II project and the work of CEIOPS

Solvency II, messages and findings from QIS 5. Carlos Montalvo Rebuelta Executive Director Brussels, 7 March 2011

An Introduction to Solvency II

LONGEVITY SWAPS. Impact of Solvency II AN EFFECTIVE, INNOVATIVE WAY TO MANAGE THE LONGEVITY RISK. Presenter: Tom O Sullivan, F.S.A, F.C.I.A, M.A.A.A.

Solvency II Interpreting the key principles

Solvency II Update. Latest developments and industry challenges (Session 10) Réjean Besner

COVER NOTE TO ACCOMPANY THE DRAFT QIS5 TECHNICAL SPECIFICATIONS

Hot Topic: Understanding the implications of QIS5

REQUEST TO EIOPA FOR TECHNICAL ADVICE ON THE REVIEW OF THE SOLVENCY II DIRECTIVE (DIRECTIVE 2009/138/EC)

1. INTRODUCTION AND PURPOSE

European insurers in the starting blocks

Solvency II Update. Craig McCulloch

Solvency II. New Rules in Europe for the Insurance Industry. Lecture at UConn Law, January 28, 2013

REPORT ON THE USE OF CAPITAL ADD-ONS DURING 2017

Solvency II: Implementation Challenges & Experiences Learned

2.1 Pursuant to article 18D of the Act, an authorised undertaking shall, except where otherwise provided for, value:

Essential adjustments for the success of Solvency II for groups

Solvency Assessment and Management (SAM)

Life under Solvency II Be prepared!

Challenger Life Company Limited Comparability of capital requirements across different regulatory regimes

Link between Pillar 1 and Pillar 2

Solvency Assessment and Management: Steering Committee Position Paper (v 4) Life SCR - Retrenchment Risk

17/06/2012. Solvency II: Implementation Challenges & Opportunities. What is Solvency II about?

Society of Actuaries in Ireland Solvency II for Beginners. Mike Frazer. 19 May 2011

2. The European insurance sector

Re: Consultation Paper on Bermuda Solvency Capital Requirement Update Proposal, November 2016

Stress Test Exercise Questions & Answers

Solvency II. Insurance and Pensions Unit, European Commission

Solvency Regulation in the UAE: A Benchmark and Impact Study

Solvency Assessment and Management. Report on the results of 1 st South African Quantitative Impact Study ( SA QIS1 )

Solvency Assessment and Management: Steering Committee Position Paper (v 3) Loss-absorbing capacity of deferred taxes

Solvency II and the Work of CEIOPS

SOLVENCY ASSESSMENT AND MANAGEMENT (SAM) FRAMEWORK

Procedia - Social and Behavioral Sciences 110 ( 2014 ) Contemporary Issues in Business, Management and Education 2013

Report on long-term guarantees measures and measures on equity risk

Judging the appropriateness of the Standard Formula under Solvency II

QIS5 Consultation Feedback: High Level Issues

Karel VAN HULLE. Head of Unit, Insurance and Pensions, DG Markt, European Commission

29th India Fellowship Seminar

Hong Kong RBC First Quantitative Impact Study

User Guide for Input Spreadsheet QIS on IORPs

Solvency Monitoring and

From Solvency I to Solvency II: a new era for capital requirements in insurance?

1. INTRODUCTION AND PURPOSE 2. DEFINITIONS

Re: Possible Solvency and Financial Condition Report components subject to assurance

PRA Solvency II update James Orr. 29 April 2015

Technical Specifications part II on the Long-Term Guarantee Assessment Final version

Client Alert August 2016

Feedback on Solvency II Draft Directive

Quantitative Impact Study 4 Summary results and main messages

EIOPA s first set of advice to the European Commission on specific items in the Solvency II Delegated Regulation

Opinion of the European Insurance and Occupational Pensions Authority on the group solvency calculation in the context of equivalence

Solvency Assessment and Management: Steering Committee Position Paper 73 1 (v 3) Treatment of new business in SCR

Financial management of insurance companies in the context of the new regime Solvency II

A. General comments. October 27, 2012

Recent Solvency II Developments for European Life Insurers and Hannover Life Re. Dr. Wolf S. Becke CEO Hannover Life Re

Tax in Solvency II. Ayesha Patel. 10 June Tel: June 2014

Effective Risk Management. Act. Luis Alberto Morales

1. INTRODUCTION AND PURPOSE

Appendix 2: Supervisory Statements

DISCLOSURE QRT REPORT Proteq Levensverzekeringen 2017

Supervisory Statement SS44/15 Solvency II: third-country insurance and pure reinsurance branches. November 2015

Final Report on public consultation No. 14/049 on Guidelines on the implementation of the long-term guarantee measures

AIG Life Insurance Company (Switzerland) Ltd. Financial Condition Report 2017

Consultation Paper. the draft proposal for. Guidelines. on the implementation of the long term. guarantee adjustments and transitional.

CEIOPS-DOC-61/10 January Former Consultation Paper 65

Solvency & Financial Condition Report Centrewrite Limited

UNIQA Insurance Group AG. Group Embedded Value 2017

RAPPORT SUR LA SOLVABILITE ET LA SITUATION FINANCIERE

Appointed Actuary Symposium 2007 Solvency II Update

Solvency and financial condition report 2017

The fourth quantitative impact study of new regulation in the insurance sector 1 Peter Paluš, Andrea Gondová

Solvency II Insights for North American Insurers. CAS Centennial Meeting Damon Paisley Bill VonSeggern November 10, 2014

Guidelines on application of outwards reinsurance arrangements to the nonlife underwriting risk submodule

Undertaking-specific parameters (USPs)

Pillar 3 reporting for Life Companies

SOLVENCY II Level 2 Implementing Measures

EIOPA's Supervisory Statement. Solvency II: Solvency and Financial Condition Report

CEA proposed amendments, April 2008

EIOPA: recent developments in insurance and pensions. EVCA Investors' Forum Geneva, 14 March 2012

REINSURANCE CONTRIBUTION UNDER SOLVENCY II STANDARD APPROACH (RISA)

Quantitative reporting templates Appendix Verslag over de solvabiliteit en de financiële toestand Loyalis Leven 2017

Regulatory Consultation Paper Round-up

Solvency II The Reporting Challenge


What do you know about Solvency II? High-level introduction for interested parties from Non-EU regions February 2013

Proposal for the Quality Assurance of the Solvency II capital requirements, own funds and balance sheet

ALM in a Solvency II World. Craig McCulloch

AVIVA Solvency and Financial Condition Report ( SFCR )

Capital Adequacy and Supervisory Assessment of Solvency Position

RISK BASED CAPITAL AND SOLVENCY

A Comparison of Solvency Systems: US and EU

UNIQA Insurance Group AG. Group Economic Capital Report 2017

2016 Public Quantitative Reporting Templates Solvency II Aegon Spaarkas N.V.

EIOPACP 13/010. Guidelines on Submission of Information to National Competent Authorities

rv de septembre - 09/09/ XC

Christina Urias SMI Task Force Chair Director, Arizona Department of Insurance

Reinsurance cessions in 2012: Set to rise or fall? The impact of reinsurance on risk capital

The Central Bank s Requirement for External Audit of Solvency II Regulatory Returns / Public Disclosures

Transcription:

aktuariat-witzel Results of the QIS5 Report Short Version Universität Basel Frühjahrssemester 2013 Dr. Ruprecht Witzel ruprecht.witzel@aktuariat-witzel.ch

On 5 July 2010 the European Commission published the QIS5 Technical Specifications The calculations were done in the second half of the year 2010 The reporting date to be used by all participants should be end December 2009 On 14 March 2011 the European Insurance and Occupational Pensions Authority (EIOPA) published the Report on the fifth Quantitative Impact Study (QIS5) for Solvency II This presentation summarizes the main results of this report in a short version Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 2

Content 1. Introduction 2. Overall Financial Impact 3. Valuation of Assets and other Liabilities 4. Technical Provisions 5. SCR Standard Formula Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 3

1. Introduction 1.3. Objectives The results of QIS5 are intended to be of use in the European Commission s development of level 2 implementing measures. To try to ensure that the results provided a representative view, the target participation rates were significantly increased from previous QIS exercises. There was a particular emphasis on increasing participation among small and medium-sized (re)insurance undertakings. QIS5 aimed to obtain detailed information on the quantitative impact of the proposals on insurers and reinsurers solvency balance sheets and also to check that the proposals were aligned with the principles and calibration targets set out in the Solvency II Framework Directive. Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 4

1. Introduction 1.3. Objectives It was also the intention to encourage undertakings and supervisors to prepare for the introduction of Solvency II and identify areas where further preparatory work may be required, and to provide a starting point for ongoing dialogue between supervisors and the industry as we move towards Solvency II implementation. Finally, it would also allow EIOPA to assess the feasibility and complexity of the proposals. Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 5

1. Introduction 1.4. Participation Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 6

Content 1. Introduction 2. Overall Financial Impact 3. Valuation of Assets and other Liabilities 4. Technical Provisions 5. SCR Standard Formula Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 7

2. Overall Financial Impact 2.1. Overall Surplus The financial position of the European insurance sector remains comfortable assessed against the standard formula SCR calculated according to the QIS5 specifications, with the eligible amount of own funds to cover the SCR/MCR exceeding the regulatory requirements by around 360bn. This surplus has decreased by c. 120bn compared to the current regime. At the same time, the margin before the MCR, the point of mandatory supervisory intervention, has increased by 200bn. Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 8

2. Overall Financial Impact 2.1. Overall Surplus Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 9

2. Overall Financial Impact 2.1. Overall Surplus Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 10

2. Overall Financial Impact 2.1. Overall Surplus Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 11

2. Overall Financial Impact 2.3. The main drivers of the surplus changes Three main drivers explain the changes in the surplus from the current regime to the Solvency II framework: the shift from the current balance sheet to the harmonized Solvency II balance sheet; the shift from the current requirements to the harmonized Solvency II capital requirements; and the differences in the own funds elements allowed to cover the requirements. The following graph shows the respective influence of these items, splitting the valuation impacts into positive and negative effects. As this revaluation changes the amount of own funds compared to the current situation, it also creates deferred tax assets or liabilities. Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 12

2. Overall Financial Impact 2.3. The main drivers of the surplus changes Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 13

2. Overall Financial Impact 2.4. Impact of diversification To calculate the Solvency II capital requirement, which is defined at the overall SCR level, the standard formula applies a modular bottom-up approach in which each of the underlying risk drivers is modeled using the same calibration as that set by the directive for the overall result. For QIS5, the sum of the individual risks modeled totaled more than 1300bn. To acknowledge the fact that the individual risks are not all expected to materialize at the same time (e.g. a shock on financial markets and a loss on underwriting risks would not necessarily crystallize at the same time), the standard formula recognizes the benefits of risk diversification through the use of linear correlation techniques. Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 14

2. Overall Financial Impact 2.4. Impact of diversification For QIS5, these diversification benefits amounted to a 466bn reduction in the total risk charge at solo level. The last stage in the derivation of the SCR recognizes that if risks were to materialize, part of their cost might be transferred onto policyholders (e.g. through a reduction in the bonuses attributed to policies with profit participation), and part of the remaining cost might result in a reduction in the future taxes expected to be paid to tax authorities. For QIS5, the expected sharing of the cost of risk crystallization with policyholders and tax authorities resulted in a 314bn reduction in the own funds needed. Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 15

2. Overall Financial Impact 2.4. Impact of diversification Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 16

2. Overall Financial Impact 2.4. Impact of diversification Overall, the final SCR of 547bn is a little above 41% of the sum of individual risks modeled. Using this overall risk reduction as a basis for calculating the reduction in individual risks gives a rough idea of the average real risk charges. Using this simple approach would for example show that while the initial risk loading for listed equity in QIS5 was 30% of the equity exposure, the final risk capital required was on average equivalent to a 12.4% capital charge. Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 17

Content 1. Introduction 2. Overall Financial Impact 3. Valuation of Assets and other Liabilities 4. Technical Provisions 5. SCR Standard Formula Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 18

3. Valuation of Assets and other Liabilities 3. Valuation of Assets and other Liabilities Outlined below is the composition of the balance sheet, for solo undertakings under the current accounting regime and the valuation principles of QIS5. Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 19

3. Valuation of Assets and other Liabilities The current balance sheet (solo) Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 20

3. Valuation of Assets and other Liabilities The current balance sheet (solo) Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 21

3. Valuation of Assets and other Liabilities The QIS5 balance sheet (solo) Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 22

3. Valuation of Assets and other Liabilities The QIS5 balance sheet (solo) Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 23

Content 1. Introduction 2. Overall Financial Impact 3. Valuation of Assets and other Liabilities 4. Technical Provisions 5. SCR Standard Formula Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 24

4. Technical Provisions 4.1. Comparison with current regime Overall gross technical provisions for all lines of business decreased by 1.4% from Solvency I to QIS5. The main differences between technical provisions under the QIS5 and Solvency I methodologies can be explained by the following: the use of a new discounting model including the use of an illiquidity premium; the absence of any surrender floor; the recognition of future premiums and charges; and the use of realistic assumptions in the best estimate calculation (i.e. no implicit prudence margin, although this is partly offset by the inclusion of an explicit risk margin in addition to the best estimate). Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 25

4. Technical Provisions 4.1. Comparison with current regime In the valuation of QIS5 liabilities, management actions and policyholders behavior, such as lapses, renewals and surrenders, were taken into account. Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 26

4. Technical Provisions 4.1. Comparison with current regime For life insurance business net technical provisions in QIS5 increased in comparison with Solvency I. This was mainly caused by the decrease in reinsurance recoverables, as gross technical provisions in fact showed a slight decrease of 1.0%. The graph below shows a comparison of life net provisions for all QIS5 participants under QIS5 and Solvency I. We note that total net provisions are greater under QIS5 than under Solvency I and that this is an increase of around 3% (for solo undertakings). Net provisions for with profit business increased by 8% under the new regime. Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 27

4. Technical Provisions 4.1. Comparison with current regime Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 28

4. Technical Provisions 4.1. Comparison with current regime For most non-life lines of business net provisions have decreased from Solvency I to QIS5; gross provisions for non-life decreased by 24.9%. Please note that equalization reserves can no longer be included in the technical provisions. The decrease between Solvency I and QIS5 for non-life business is mainly due to the discounting of future cash flows, and the exclusion of the implicit safety margin included in technical provisions through prudent and cautious assumptions, partially offset by the inclusion of an explicit risk margin. The observed changes could also be partially due to different segmentations between the two regimes. Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 29

4. Technical Provisions 4.1. Comparison with current regime Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 30

4. Technical Provisions 4.2. Discount rate and illiquidity premium General comment The effect of the introduction of the illiquidity premium in the valuation of technical provisions in QIS5 can be estimated as being almost 1% of the value of technical provisions (which represents around 15% of SCR). Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 31

4. Technical Provisions 4.2. Discount rate and illiquidity premium The 50% Bucket The most common products where 50% of the illiquidity premium was used were nonlife in general, unit- and index-linked business, life without profit participation, SLT (Similar to Life Techniques) health, non-slt health and reinsurance (both life and non-life). The 50% bucket has a share of round about 35%. Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 32

4. Technical Provisions 4.2. Discount rate and illiquidity premium The 75% Bucket The most common products where 75% of the illiquidity premium was used were life insurance with profit participation in general, pure savings products, unitand index-linked insurance with guarantees, and various types of annuities. The 75% bucket has a share of round about 55% The 100% Bucket The most common products where 100% of the illiquidity premium was used were different types of annuities (including annuities from non-life). The 100% bucket has a share of only round about 8%. Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 33

4. Technical Provisions 4.3. Risk margin The two following graphs show for EEA solo undertakings the ratio of the risk margin to net technical provisions for life and non-life obligations Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 34

4. Technical Provisions 4.3. Risk margin Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 35

4. Technical Provisions 4.3. Risk margin Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 36

Content 1. Introduction 2. Overall Financial Impact 3. Valuation of Assets and other Liabilities 4. Technical Provisions 5. SCR Standard Formula Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 37

5. SCR Standard Formula 5.1. The overall SCR The Solvency Capital Requirement (SCR) is the riskbased capital requirement for undertakings under Solvency II. It is calibrated to a 99.5% Value at Risk confidence level over one year. In structure the SCR is composed of a number of modules which in turn are composed of sub-modules. The capital requirements arising from these submodules and modules are aggregated using a correlation matrix. Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 38

5. SCR Standard Formula 5.1. The overall SCR (all; SCR = 100%) Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 39

5. SCR Standard Formula 5.1. The overall SCR (all; BSCR = 100%) Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 40

5. SCR Standard Formula 5.1. The overall SCR (all; SCR in % of BSCR) Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 41

5. SCR Standard Formula 5.1. The overall SCR (Life; BSCR = 100%) Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 42

5. SCR Standard Formula 5.1. The overall SCR (Non-Life; BSCR = 100%) Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 43

5. SCR Standard Formula 5.5. Market risk (all; Market Risk = 100%) Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 44

5. SCR Standard Formula 5.7. Life Underwriting risk (all; Life Risk = 100%) Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 45

5. SCR Standard Formula 5.7. Life Underwriting risk (Life; Life Risk = 100%) Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 46

5. SCR Standard Formula 5.9. Non-life Underwriting risk (Non-L; Non-Life Risk = 100%) Results QIS5 Short Version Dr. Ruprecht Witzel; FS 13 47